Literature DB >> 2787476

A nuclear magnetic resonance study of the interactions of the antimalarials chloroquine, quinacrine, quinine and mefloquine with dipalmitoylphosphatidylcholine bilayers.

R Zidovetzki1, I W Sherman, A Atiya, H De Boeck.   

Abstract

The interaction of four cationic amphiphilic antimalarials (chloroquine, quinacrine, mefloquine and quinine) with model dipalmitoylphosphatidylcholine (DPPC) bilayer membranes was studied using 2H- and 31P-nuclear magnetic resonance (NMR). The results showed no significant perturbation of lipid bilayer structure by the presence of chloroquine up to a molar ratio of 1:2 of drug to lipid. Addition of quinacrine to DPPC at the same molar ratio resulted in a 2.5 degrees C decrease in the gel to liquid crystalline phase transition temperature (Tc) of the lipids, with only a small perturbation of the order parameters of the lipid side chains. 31P-NMR spectra of quinacrine-DPPC mixtures indicated a quinacrine-induced change of head group conformation of DPPC above the Tc. These findings are consistent with quinacrine interacting only with the surface of DPPC bilayers. In contrast, both mefloquine and quinine exhibited stronger interactions with DPPC, decreasing the Tc of the lipids by 10 degrees C and 9 degrees C, respectively, and causing significant disordering of the lipid side chains. The basic bilayer structure of DPPC was, however, maintained, even at the highest molar ratio 1:2 of drug to lipid. Such behavior is consistent with penetration of both mefloquine and quinine into the interior of the bilayers. This ability of mefloquine and quinine, but not chloroquine and quinacrine, to intercalate into lipid bilayers correlates with their lower pKa values, which ensures that at physiological pH significant amounts of mefloquine or quinine remain in their uncharged lipophilic form.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2787476     DOI: 10.1016/0166-6851(89)90206-5

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  8 in total

1.  Differential effects of quinoline antimalarials on endocytosis in Plasmodium falciparum.

Authors:  Lindi Roberts; Timothy J Egan; Keith A Joiner; Heinrich C Hoppe
Journal:  Antimicrob Agents Chemother       Date:  2008-03-03       Impact factor: 5.191

2.  Multimodal Investigation into the Interaction of Quinacrine with Microcavity-Supported Lipid Bilayers.

Authors:  Nirod Kumar Sarangi; Amrutha Prabhakaran; Tia E Keyes
Journal:  Langmuir       Date:  2022-05-13       Impact factor: 4.331

3.  Mefloquine-induced disruption of calcium homeostasis in mammalian cells is similar to that induced by ionomycin.

Authors:  D Caridha; D Yourick; M Cabezas; L Wolf; T H Hudson; G S Dow
Journal:  Antimicrob Agents Chemother       Date:  2007-11-12       Impact factor: 5.191

4.  Anti-malarial activity of a non-piperidine library of next-generation quinoline methanols.

Authors:  Erin Milner; William McCalmont; Jayendra Bhonsle; Diana Caridha; Jose Cobar; Sean Gardner; Lucia Gerena; Duane Goodine; Charlotte Lanteri; Victor Melendez; Norma Roncal; Jason Sousa; Peter Wipf; Geoffrey Stuart Dow
Journal:  Malar J       Date:  2010-02-11       Impact factor: 2.979

5.  Quinine uptake by human polymorphonuclear neutrophils.

Authors:  J el Benna; C Pasquier; M T Labro
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Central nervous system exposure of next generation quinoline methanols is reduced relative to mefloquine after intravenous dosing in mice.

Authors:  Geoffrey S Dow; Erin Milner; Ian Bathurst; Jayendra Bhonsle; Diana Caridha; Sean Gardner; Lucia Gerena; Michael Kozar; Charlotte Lanteri; Anne Mannila; William McCalmont; Jay Moon; Kevin D Read; Suzanne Norval; Norma Roncal; David M Shackleford; Jason Sousa; Jessica Steuten; Karen L White; Qiang Zeng; Susan A Charman
Journal:  Malar J       Date:  2011-06-06       Impact factor: 2.979

Review 7.  Potential Antiviral Action of Alkaloids.

Authors:  Frage L Abookleesh; Bader S Al-Anzi; Aman Ullah
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

8.  Repurposing Quinacrine for Treatment of Malignant Mesothelioma: In-Vitro Therapeutic and Mechanistic Evaluation.

Authors:  Nishant S Kulkarni; Bhuvaneshwar Vaidya; Vineela Parvathaneni; Debarati Bhanja; Vivek Gupta
Journal:  Int J Mol Sci       Date:  2020-08-31       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.